Comerica Bank Buys 157,198 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Comerica Bank increased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 13.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,357,628 shares of the company's stock after purchasing an additional 157,198 shares during the quarter. Comerica Bank owned approximately 0.80% of Option Care Health worth $31,497,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp acquired a new position in Option Care Health in the fourth quarter worth approximately $26,000. UMB Bank n.a. increased its stake in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC lifted its stake in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC boosted its holdings in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in Option Care Health during the fourth quarter worth $47,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

Option Care Health stock traded up $0.78 during mid-day trading on Friday, reaching $32.95. The company had a trading volume of 3,358,100 shares, compared to its average volume of 1,826,657. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The firm has a market cap of $5.41 billion, a price-to-earnings ratio of 27.69, a PEG ratio of 2.30 and a beta of 1.07. The company has a 50 day moving average of $33.35 and a 200-day moving average of $28.83. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company's quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the company earned $0.26 EPS. On average, sell-side analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. JMP Securities reiterated a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $38.00 to $40.00 in a research report on Wednesday. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Barrington Research reissued an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.